Quick Heal Technologies posts its Q4 and FY22 results with strong growth in the Enterprise segment

Quick Heal

Quick Heal Technologies Limited, one of the leading providers of cybersecurity and data protection solutions to consumers, businesses and government, reported its unaudited results for the quarter and full year ended 31st March 2022.

Consolidated Financial Highlights:

Particulars ( Cr) FY22 FY21 YoY Change
Revenue 342 333 2.7%
EBITDA 107 141 (24.5%)
EBITDA Margin 31.3% 42.5% (1121bps)
PAT 83 107 (22.2%)
PAT Margin 24.3% 32.1% (778bps)

Dr. Kailash Katkar, Managing Director and Chief Executive Officer, Quick Heal Technologies Limited, said, “Our 4th quarter and full year results continues to be strong. We have delivered growth in our revenues despite 2 waves of Covid hitting the country largely during the year. We have launched couple of new age tech products in the year to suit the needs of our Enterprise customers and have similar in pipelines in the next couple of years.

Our strategy is to grow multifold in the years to come and we are taking right steps towards it. We have started investing heavily into our R&D and S&M through this year catering to the right offering to the customers into the right market through best channels,” he added.

Mr. Navin Sharma, Chief Financial Officer, Quick Heal Technologies Limited, said, “We have delivered robust results in FY22, through continued strong demand for our products. The enterprise business which we incubated few years ago has caught momentum and has crossed an ARR of 100Cr for the first time and has grown by 23% YoY and 33% QoQ. We are investing more than 50% of our revenues for the future growth. R&D investments for the year stands at 26% while the S&M stands at 24%. Our balance sheet remains strong with zero debt and cash and cash equivalents of ₹ 359 Cr as on 31st March 2022. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow. We have proposed a dividend of ₹4.5 per share in line with our dividend distribution policy”

Segmental performance for the quarter ended 31st March 2022:

  • Retail segment revenue stood at ₹287 Cr as compared to ₹299 Cr in the previous year despite spillover revenue of ₹30 Cr in the last year.
  • Enterprise and Government segment revenue stood at ₹82Cr as compared to 66 Cr in the corresponding year, up 23.4% YoY.

Key updates for Q4FY22/FY22:

  • Enterprise business grew by 23.4% YoY for the full year FY22, with an ARR (Annualised Revenue Run Rate) of ₹107 Cr
  • Removing the impact of spillover revenue, retail business grew by 6% for the full year
  • Couple of new age tech beta products launched for the Enterprise cybersecurity customers with continual upgrades of existing product lines in the Retail & Enterprise space.
  • Completed buyback at Rs 245 per share, amounting to an aggregate of Rs 155 Cr.
  • Quick Heal has continued its efforts in the quarter towards serving the community by donating 3 mobile clinics in Bihar, Nagpur & Indore, helping school kids in Maharashtra through mental wellness program and creating cyber awareness in college students through innovative methods like street plays.

Related posts

Pega Releases Inaugural Global Impact Report Highlighting its Environmental, Social, and Governance Progress

SSI Bureau

Vertiv Survey Shows Significant Growth and Investment in Edge-Network

SSI Bureau

Private Sector Expects to Lose Control of AI Governance Within Five Years: Pegasystems

SSI Bureau

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More